Halozyme
HALO
137 hedge funds and large institutions have $1.35B invested in Halozyme in 2015 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 20 closing their positions.
92% more call options, than puts
Call options by funds: $18.1M | Put options by funds: $9.43M
53% more capital invested
Capital invested by funds: $882M → $1.35B (+$465M)
38% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 40
30% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 20
4% more funds holding
Funds holding: 132 → 137 (+5)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$58.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$28.4M |
| 3 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$13.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.49M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$16.7M |
| 2 |
JCG
JHL Capital Group
Chicago,
Illinois
|
-$15.9M |
| 3 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$13.7M |
| 4 |
State Street
Boston,
Massachusetts
|
-$9.35M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$7.61M |
HALO Hedge Fund Activity: Q1 2015 in Review
137 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2015, worth a combined $1.35B — up 53% from $882M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new HALO positions and 20 closed out — a net gain of 6 holders — while 55 added to existing stakes and 40 trimmed.
The largest buyer was Millennium Management, adding an estimated $58.2M. The largest seller was QVT Financial, cutting an estimated $16.7M.
- 137 institutional investors held Halozyme (HALO) as of Q1 2015, up from 132 in Q4 2014.
- Funds reported $1.35B of Halozyme stock for Q1 2015, up 53% quarter-over-quarter.
- 26 funds opened new Halozyme positions in Q1 2015 and 20 closed out, a net change of +6 holders.
- The largest Halozyme buyer in Q1 2015 was Millennium Management, an estimated $58.2M added.
- The largest Halozyme seller in Q1 2015 was QVT Financial, an estimated $16.7M sold.
Based on aggregated 13F filings for Q1 2015.